Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression

Neurosurgical Review(2026)10.1007/s10143-025-04088-7Source: DataRank Database

Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression is a research paper published in Neurosurgical Review (2026). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.00)OA: closedTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Atsushi Kambe ORCID,Hidefumi Amisaki,Tomohiro Hosoya,Makoto Sakamoto ORCID,Masamichi Kurosaki ORCID

Live enrichment

PubMed:41622339 OpenAlex:https://openalex.org/W7127049943

FWCI

0.00

Citation Percentile

0.1%

closedLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

publisherhttps://link.springer.com/content/pdf/10.1007/s10143-025-04088-7.pdf

publisherhttps://link.springer.com/article/10.1007/s10143-025-04088-7

journalhttps://doi.org/10.1007/s10143-025-04088-7

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41622339

Fields of Study

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in CancerBrain Metastases and Treatment

MeSH Terms

BevacizumabAntineoplastic Agents, ImmunologicalBrain NeoplasmsGlioblastomaHumansHypertensionPrognosisTreatment OutcomeAngiogenesis Inhibitors

Keywords

BevacizumabHazard ratioBiomarkerMeta-analysisGlioblastomaOverall survivalAdverse effectProportional hazards modelHypertensionSurvivalAngiogenesis

Sustainable Development Goals

SDG 0: Good health and well-being

Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression

FAIR Checklist

Authors (6)

Impact

Open Access

Topics